Experimental Observation on the Renal Protective Effects of Losartan and Benazepril During the Early Phase of Disease Development
胡波,李红叶,杨霁云,丁洁,张敬京
DOI: https://doi.org/10.3760/j.issn:0578-1310.2001.05.012
2001-01-01
Abstract:Objective AngiotensinⅡ is thought to be a crucial factor in progressive renal injury. Losartan, an angiotensinⅡ type 1 receptor antagonist (AT1A), selectively inhibits the effect of angiotensinⅡ via AT1 receptor blockade. Benazepril, a new type angiotensin converting enzyme inhibitor (ACEI), fairly well inhibits angiotensin converting enzyme in circulation and tissue. The purpose of this study was to observe the renal protective effects of these 2 agents in rats with nephropathy during the early phase of disease development. Methods All experiments were performed on male 6 month old Sprague Dawley rats weighing about 400 g. Sixteen rats were divided into four groups: normal control rats ( n =4), benazepril treated rats ( n =4), losartan treated rats ( n =4) and non drug treated rats ( n =4). Normal control rats were subjected to sham operation and were injected with normal saline after one week through the tail vein. The rest groups were uninephrectomized and injected adriamycin (5 mg/kg) after one week through the tail vein. Groups Ⅱ or III was treated with benazepril 6 mg/(kg·d) or losartan 5 mg/(kg·d); groups Ⅰ and Ⅳ were allowed to have free access to standard rat chow and tap water for 5 weeks. The protein in urine, serum total protein and albumin, serum creatinine, blood urea nitrogen and serum cholesterol were measured at the 3rd or 5th week, the renal pathological changes of the remnant kidney were investigated at the 5th week when the rats were sacrificed. Results At the 3rd week of the experiment, the protein levels in urine were 2.6(1.3 5.6) mg/24 h, 130.3(100.9 176.8) mg/24 h, 42.7(41 9 44.2) mg/24 h and 105.8(85.1 144.9) mg/24 h ( H =11.65, P 0.01) in normal control, benazepril treated, losartan treated and non drug treated groups, respectively. At the 5th week, the protein levels in urine were 4.4(0.7 5.8) mg/24 h, 54.8(32.8 72.0) mg/24 h, 26.7(25.6 28.1) mg/24 h and 43.2(31.6 50.9) mg/24 h ( H =11.30, P 0.01); the serum cholesterol was (1.9±0.3) mmol/L, (5.0±1.6) mmol/L, (4.4±1.4) mmol/L, (8.7±2.4) mmol/L ( F =11.26, P 0.01), respectively; mesangial expansion rate were 7 3(1.4 12.8)%, 30.3(8.2 64.5)%, 32.8(6.0 55.0)%, 65.7(26.8 86.1)% ( H =8.89, P 0.01); sclerosis index were 0.7(0 1.3), 3.3(1.2 6.2), 3.5(1.0 6.3), 12.6(6.7 16.0) ( H =10.66, P 0.01) in normal control, benazepril treated, losartan treated and non drug treated groups, respectively. Conclusion During the 3rd to 5th week of experiment , angiotensinⅡ blocker had protecting effect on the kidney in uninephrectomized rats with adriamycin nephropathy.